Targeting of the lysophosphatidic acid receptor 1 (LPA1) gene that has been implicated in promoting metastasis, via the specific inhibitor Debio-0719, was shown to induce dormancy at the secondary tumor site in a breast cancer model [97]. The gene discussed is LPAR1; the disease is breast carcinoma.